Cargando…
The natural history of hypertrophic cardiomyopathy
In the early years of the disease recognition, hypertrophic cardiomyopathy (HCM) was viewed as an ominous disease with unfavourable prognosis and with an annual mortality between 4% and 6%. At that time, 73% of the patients reported in the literature came from only two referral centres. With the int...
Autores principales: | Autore, Camillo, Musumeci, Maria Beatrice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904071/ https://www.ncbi.nlm.nih.gov/pubmed/33654461 http://dx.doi.org/10.1093/eurheartj/suaa125 |
Ejemplares similares
-
Old and new therapeutic solutions in the treatment of hypertrophic cardiomyopathy
por: Autore, Camillo, et al.
Publicado: (2023) -
Left Ventricular Remodeling in Hypertrophic Cardiomyopathy: An Overview of Current Knowledge
por: Musumeci, Beatrice, et al.
Publicado: (2021) -
Insights from Cardiopulmonary Exercise Testing in Pediatric Patients with Hypertrophic Cardiomyopathy
por: Gallo, Giovanna, et al.
Publicado: (2021) -
A Next-Generation Sequencing Approach to Identify Gene Mutations in Early- and Late-Onset Hypertrophic Cardiomyopathy Patients of an Italian Cohort
por: Rubattu, Speranza, et al.
Publicado: (2016) -
TNNI3 and KCNQ1 co-inherited variants in a family with hypertrophic cardiomyopathy and long QT phenotypes: A case report
por: Cava, Francesco, et al.
Publicado: (2021)